SENEA:NASDAQSeneca Foods Corp. Analysis
Data as of 2026-04-30 - not real-time
$134.71
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Seneca Foods is trading above its long‑term 200‑day moving average but beneath the shorter‑term 20‑day and 50‑day averages, suggesting the stock respects a broader uptrend while facing near‑term pressure. The 14‑day RSI sits in the low‑forties, hinting at modest bearish momentum but still far from oversold conditions, and the MACD line remains below its signal with a negative histogram, reinforcing a bearish technical bias. Volume has been on a downtrend, which together with a high 30‑day volatility reading points to a relatively thin trading environment and amplified price swings, although the beta is notably low, indicating limited correlation with broader market movements.
Fundamentally, the company appears attractively priced: a sub‑10 price‑to‑earnings multiple, a price‑to‑book ratio near unity, and a discounted cash‑flow valuation that more than doubles the current market price, all of which signal potential undervaluation. Revenue growth is modest and margins are thin, with no dividend paid, but operating cash flow comfortably exceeds free cash flow and the balance sheet shows manageable leverage. Recent market sentiment, reflected in a strong three‑month rally and an “Extreme Greed” market mood, has lifted the stock, yet the underlying fundamentals remain the primary catalyst for a potential re‑rating.
Fundamentally, the company appears attractively priced: a sub‑10 price‑to‑earnings multiple, a price‑to‑book ratio near unity, and a discounted cash‑flow valuation that more than doubles the current market price, all of which signal potential undervaluation. Revenue growth is modest and margins are thin, with no dividend paid, but operating cash flow comfortably exceeds free cash flow and the balance sheet shows manageable leverage. Recent market sentiment, reflected in a strong three‑month rally and an “Extreme Greed” market mood, has lifted the stock, yet the underlying fundamentals remain the primary catalyst for a potential re‑rating.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price below short‑term moving averages
- bearish MACD divergence
- decreasing volume and high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- substantial gap between DCF fair value and market price
- low beta reducing market‑wide risk
- solid operating cash flow supporting earnings stability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- stable consumer‑defensive positioning with diversified product mix
- undervalued valuation metrics relative to peers
- manageable debt levels and consistent cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth1.10%
Profit Margin5.58%
P/E Ratio10.4
ROE13.57%
ROA6.67%
Debt/Equity41.21
P/B Ratio1.3
Op. Cash Flow$206.0M
Free Cash Flow$151.8M
Technical Analysis
TrendBullish
RSI40.4
Support$121.36
Resistance$167.52
MA 20$147.77
MA 50$143.91
MA 200$119.94
MACDBearish
VolumeDecreasing
Fear & Greed Index88.32
Valuation
Fair Value$272.33
GradeUndervalued
TypeValue
Risk Assessment
Beta0.20
Volatility60.81%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.